Industry Research Reports

Home > Reports > Medical Care > Healthcare-associated Infectious Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Healthcare-associated Infectious Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 132 Pages

Report ld: 2625396

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diagnosis of health care-associated infectious diseases.

The global market for Healthcare-associated Infectious Disease Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Healthcare-associated Infectious Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Healthcare-associated Infectious Disease Diagnostics by region & country, by Type, and by Application.

The Healthcare-associated Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare-associated Infectious Disease Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
Healthcare-associated Infectious Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Healthcare-associated Infectious Disease Diagnostics Companies Covered
Abbott, Accelerate Diagnostics, BD, bioMrieux, Bio-Rad, DiaSorin Molecular, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, OpGen, QIAGEN, Quidel, Thermo Fisher Scientific, Trinity Biotech, Danaher
Global Healthcare-associated Infectious Disease Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Healthcare-associated Infectious Disease Diagnostics Market, Segment by Type
Urinary Tract Infections

Surgical Site Infections

Hospital-acquired Pneumonia

BloodStream Infections

Gastrointestinal Infections
Global Healthcare-associated Infectious Disease Diagnostics Market, Segment by Application
Hospitals

Clinics

ASCs
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Healthcare-associated Infectious Disease Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Healthcare-associated Infectious Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Healthcare-associated Infectious Disease Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Healthcare-associated Infectious Disease Diagnostics Product Introduction
    1.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast
    1.3 Healthcare-associated Infectious Disease Diagnostics Market Trends & Drivers
        1.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends
        1.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers & Opportunity
        1.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
        1.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Healthcare-associated Infectious Disease Diagnostics Players Revenue Ranking (2023)
    2.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies Healthcare-associated Infectious Disease Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Healthcare-associated Infectious Disease Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Healthcare-associated Infectious Disease Diagnostics
    2.6 Healthcare-associated Infectious Disease Diagnostics Market Competitive Analysis
        2.6.1 Healthcare-associated Infectious Disease Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Urinary Tract Infections
        3.1.2 Surgical Site Infections
        3.1.3 Hospital-acquired Pneumonia
        3.1.4 BloodStream Infections
        3.1.5 Gastrointestinal Infections
    3.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type
        3.2.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Value, by Type (2019-2030)
        3.2.3 Global Healthcare-associated Infectious Disease Diagnostics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 ASCs
    4.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application
        4.2.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global Healthcare-associated Infectious Disease Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region
        5.1.1 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        5.2.2 North America Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        5.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        5.5.2 South America Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value
    6.3 United States
        6.3.1 United States Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.3.2 United States Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.5.2 China Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.6.2 Japan Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019-2030
        6.9.2 India Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Healthcare-associated Infectious Disease Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Profile
        7.1.2 Abbott Main Business
        7.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.1.4 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Recent Developments
    7.2 Accelerate Diagnostics
        7.2.1 Accelerate Diagnostics Profile
        7.2.2 Accelerate Diagnostics Main Business
        7.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.2.4 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Accelerate Diagnostics Recent Developments
    7.3 BD
        7.3.1 BD Profile
        7.3.2 BD Main Business
        7.3.3 BD Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.3.4 BD Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 bioMrieux Recent Developments
    7.4 bioMrieux
        7.4.1 bioMrieux Profile
        7.4.2 bioMrieux Main Business
        7.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.4.4 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 bioMrieux Recent Developments
    7.5 Bio-Rad
        7.5.1 Bio-Rad Profile
        7.5.2 Bio-Rad Main Business
        7.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.5.4 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 Bio-Rad Recent Developments
    7.6 DiaSorin Molecular
        7.6.1 DiaSorin Molecular Profile
        7.6.2 DiaSorin Molecular Main Business
        7.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.6.4 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 DiaSorin Molecular Recent Developments
    7.7 F. Hoffmann-La Roche
        7.7.1 F. Hoffmann-La Roche Profile
        7.7.2 F. Hoffmann-La Roche Main Business
        7.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.7.4 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 F. Hoffmann-La Roche Recent Developments
    7.8 Luminex
        7.8.1 Luminex Profile
        7.8.2 Luminex Main Business
        7.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.8.4 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Luminex Recent Developments
    7.9 Meridian Bioscience
        7.9.1 Meridian Bioscience Profile
        7.9.2 Meridian Bioscience Main Business
        7.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.9.4 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 Meridian Bioscience Recent Developments
    7.10 OpGen
        7.10.1 OpGen Profile
        7.10.2 OpGen Main Business
        7.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.10.4 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.10.5 OpGen Recent Developments
    7.11 QIAGEN
        7.11.1 QIAGEN Profile
        7.11.2 QIAGEN Main Business
        7.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.11.4 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.11.5 QIAGEN Recent Developments
    7.12 Quidel
        7.12.1 Quidel Profile
        7.12.2 Quidel Main Business
        7.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.12.4 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.12.5 Quidel Recent Developments
    7.13 Thermo Fisher Scientific
        7.13.1 Thermo Fisher Scientific Profile
        7.13.2 Thermo Fisher Scientific Main Business
        7.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.13.4 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.13.5 Thermo Fisher Scientific Recent Developments
    7.14 Trinity Biotech
        7.14.1 Trinity Biotech Profile
        7.14.2 Trinity Biotech Main Business
        7.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.14.4 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.14.5 Trinity Biotech Recent Developments
    7.15 Danaher
        7.15.1 Danaher Profile
        7.15.2 Danaher Main Business
        7.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
        7.15.4 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.15.5 Danaher Recent Developments

 8 Industry Chain Analysis
    8.1 Healthcare-associated Infectious Disease Diagnostics Industrial Chain
    8.2 Healthcare-associated Infectious Disease Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Healthcare-associated Infectious Disease Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 Healthcare-associated Infectious Disease Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Healthcare-associated Infectious Disease Diagnostics Market Trends
    Table 2. Healthcare-associated Infectious Disease Diagnostics Market Drivers & Opportunity
    Table 3. Healthcare-associated Infectious Disease Diagnostics Market Challenges
    Table 4. Healthcare-associated Infectious Disease Diagnostics Market Restraints
    Table 5. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Healthcare-associated Infectious Disease Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Healthcare-associated Infectious Disease Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Healthcare-associated Infectious Disease Diagnostics
    Table 10. Global Healthcare-associated Infectious Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Healthcare-associated Infectious Disease Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Healthcare-associated Infectious Disease Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Healthcare-associated Infectious Disease Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Healthcare-associated Infectious Disease Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. Accelerate Diagnostics Basic Information List
    Table 37. Accelerate Diagnostics Description and Business Overview
    Table 38. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Accelerate Diagnostics (2019-2024)
    Table 40. Accelerate Diagnostics Recent Developments
    Table 41. BD Basic Information List
    Table 42. BD Description and Business Overview
    Table 43. BD Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of BD (2019-2024)
    Table 45. BD Recent Developments
    Table 46. bioMrieux Basic Information List
    Table 47. bioMrieux Description and Business Overview
    Table 48. bioMrieux Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of bioMrieux (2019-2024)
    Table 50. bioMrieux Recent Developments
    Table 51. Bio-Rad Basic Information List
    Table 52. Bio-Rad Description and Business Overview
    Table 53. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Bio-Rad (2019-2024)
    Table 55. Bio-Rad Recent Developments
    Table 56. DiaSorin Molecular Basic Information List
    Table 57. DiaSorin Molecular Description and Business Overview
    Table 58. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of DiaSorin Molecular (2019-2024)
    Table 60. DiaSorin Molecular Recent Developments
    Table 61. F. Hoffmann-La Roche Basic Information List
    Table 62. F. Hoffmann-La Roche Description and Business Overview
    Table 63. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of F. Hoffmann-La Roche (2019-2024)
    Table 65. F. Hoffmann-La Roche Recent Developments
    Table 66. Luminex Basic Information List
    Table 67. Luminex Description and Business Overview
    Table 68. Luminex Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Luminex (2019-2024)
    Table 70. Luminex Recent Developments
    Table 71. Meridian Bioscience Basic Information List
    Table 72. Meridian Bioscience Description and Business Overview
    Table 73. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Meridian Bioscience (2019-2024)
    Table 75. Meridian Bioscience Recent Developments
    Table 76. OpGen Basic Information List
    Table 77. OpGen Description and Business Overview
    Table 78. OpGen Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of OpGen (2019-2024)
    Table 80. OpGen Recent Developments
    Table 81. QIAGEN Basic Information List
    Table 82. QIAGEN Description and Business Overview
    Table 83. QIAGEN Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of QIAGEN (2019-2024)
    Table 85. QIAGEN Recent Developments
    Table 86. Quidel Basic Information List
    Table 87. Quidel Description and Business Overview
    Table 88. Quidel Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Quidel (2019-2024)
    Table 90. Quidel Recent Developments
    Table 91. Thermo Fisher Scientific Basic Information List
    Table 92. Thermo Fisher Scientific Description and Business Overview
    Table 93. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Thermo Fisher Scientific (2019-2024)
    Table 95. Thermo Fisher Scientific Recent Developments
    Table 96. Trinity Biotech Basic Information List
    Table 97. Trinity Biotech Description and Business Overview
    Table 98. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Trinity Biotech (2019-2024)
    Table 100. Trinity Biotech Recent Developments
    Table 101. Danaher Basic Information List
    Table 102. Danaher Description and Business Overview
    Table 103. Danaher Healthcare-associated Infectious Disease Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Healthcare-associated Infectious Disease Diagnostics Business of Danaher (2019-2024)
    Table 105. Danaher Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Healthcare-associated Infectious Disease Diagnostics Downstream Customers
    Table 109. Healthcare-associated Infectious Disease Diagnostics Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Healthcare-associated Infectious Disease Diagnostics Product Picture
    Figure 2. Global Healthcare-associated Infectious Disease Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
    Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2023
    Figure 7. Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Urinary Tract Infections Picture
    Figure 9. Surgical Site Infections Picture
    Figure 10. Hospital-acquired Pneumonia Picture
    Figure 11. BloodStream Infections Picture
    Figure 12. Gastrointestinal Infections Picture
    Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospitals
    Figure 16. Product Picture of Clinics
    Figure 17. Product Picture of ASCs
    Figure 18. Global Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Healthcare-associated Infectious Disease Diagnostics Sales Value (%), (2019-2030)
    Figure 31. United States Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Healthcare-associated Infectious Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Healthcare-associated Infectious Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Healthcare-associated Infectious Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 52. Healthcare-associated Infectious Disease Diagnostics Industrial Chain
    Figure 53. Healthcare-associated Infectious Disease Diagnostics Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

Diagnosis of health care-associated infectious diseases.

The global market for Healthcare-associated Infectious Disease Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation